New dosimeter take the Edge off noise pollution

Noise monitoring

New dosimeter take the Edge off noise pollution

27 Sep, 2019

Published over 6 years ago. See the latest and most current information on Noise monitoring.

Quest noise dosimeters, from TSI, are powerful and intuitive instruments designed for identifying hearing loss threats in all environments. After acquiring the Quest brand of products from 3M in 2018, TSI recently launched the Quest Edge 4+ noise dosimeter. The Edge 4+ lets safety professionals monitor a worker's noise exposure in real-time with the Edge dB mobile app. The ability for a safety professional to program, monitor, and capture survey data at a safe distance allows the worker to perform their tasks without interruption. The Edge 4+ noise dosimeter with Bluetooth option syncs to the Edge dB mobile app for total management of the dosimeter.

"After demonstrating the benefits of the new Quest Edge 4+ at AIHce and ASSE industry conferences, we have received tremendous positive feedback regarding the ability to monitor noise levels without disrupting workers," said Troy Tillman, Business Director for Test & Measurement Instrumentation at TSI. "This innovative offering adds to our comprehensive portfolio of solutions for Occupational Health and Safety Professionals."

The Edge product line of noise dosimeters is shoulder-mounted, providing ergonomic, convenient measurements. Units are compact, with large displays and intuitive interfaces to provide crucial information at a glance and in real-time. 

Latest News

IET Guide 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Portable fluorescence reader could bring forward molecular tests for use at home
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Vietnam’s E10 rollout puts fuel testing capacity under closer scrutiny
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow